PAHC
Price
$12.10
Change
-$0.12 (-0.98%)
Updated
Feb 21, 9:34 AM EST
75 days until earnings call
VTRS
Price
$13.28
Change
+$0.04 (+0.30%)
Updated
Feb 21, 9:49 AM EST
7 days until earnings call
Ad is loading...

PAHC vs VTRS ᐉ Comparison: Which is Better to Invest?

Header iconPAHC vs VTRS Comparison
Open Charts PAHC vs VTRSBanner chart's image
Phibro Animal Health
Price$12.10
Change-$0.12 (-0.98%)
Volume$300
CapitalizationN/A
Viatris
Price$13.28
Change+$0.04 (+0.30%)
Volume$9.48K
CapitalizationN/A
View a ticker or compare two or three
PAHC vs VTRS Comparison Chart

Loading...

PAHCDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VTRSDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
PAHC vs. VTRS commentary
Feb 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PAHC is a Buy and VTRS is a Hold.

COMPARISON
Comparison
Feb 21, 2024
Stock price -- (PAHC: $12.23 vs. VTRS: $13.24)
Brand notoriety: PAHC and VTRS are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: PAHC: 97% vs. VTRS: 140%
Market capitalization -- PAHC: $488.88M vs. VTRS: $15.88B
PAHC [@Pharmaceuticals: Other] is valued at $488.88M. VTRS’s [@Pharmaceuticals: Other] market capitalization is $15.88B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $85.42B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $2.96B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PAHC’s FA Score shows that 2 FA rating(s) are green whileVTRS’s FA Score has 2 green FA rating(s).

  • PAHC’s FA Score: 2 green, 3 red.
  • VTRS’s FA Score: 2 green, 3 red.
According to our system of comparison, PAHC is a better buy in the long-term than VTRS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PAHC’s TA Score shows that 5 TA indicator(s) are bullish while VTRS’s TA Score has 4 bullish TA indicator(s).

  • PAHC’s TA Score: 5 bullish, 4 bearish.
  • VTRS’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, PAHC is a better buy in the short-term than VTRS.

Price Growth

PAHC (@Pharmaceuticals: Other) experienced а +7.93% price change this week, while VTRS (@Pharmaceuticals: Other) price change was +10.61% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +1.97%. For the same industry, the average monthly price growth was +1.79%, and the average quarterly price growth was +21.74%.

Reported Earning Dates

PAHC is expected to report earnings on May 06, 2024.

VTRS is expected to report earnings on May 06, 2024.

Industries' Descriptions

@Pharmaceuticals: Other (+1.97% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
A.I.dvisor published
a Summary for PAHC with price predictions.
OPEN
A.I.dvisor published
a Summary for VTRS with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
VTRS($15.9B) has a higher market cap than PAHC($489M). PAHC has higher P/E ratio than VTRS: PAHC (33.05) vs VTRS (8.77). VTRS YTD gains are higher at: 22.253 vs. PAHC (5.596). VTRS has higher annual earnings (EBITDA): 6.07B vs. PAHC (83.7M). VTRS has more cash in the bank: 1.56B vs. PAHC (92.5M). PAHC has less debt than VTRS: PAHC (513M) vs VTRS (18.6B). VTRS has higher revenues than PAHC: VTRS (15.5B) vs PAHC (982M).
PAHCVTRSPAHC / VTRS
Capitalization489M15.9B3%
EBITDA83.7M6.07B1%
Gain YTD5.59622.25325%
P/E Ratio33.058.77377%
Revenue982M15.5B6%
Total Cash92.5M1.56B6%
Total Debt513M18.6B3%
FUNDAMENTALS RATINGS
PAHC vs VTRS: Fundamental Ratings
PAHC
VTRS
OUTLOOK RATING
1..100
2121
VALUATION
overvalued / fair valued / undervalued
1..100
4
Undervalued
5
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
8273
PRICE GROWTH RATING
1..100
504
P/E GROWTH RATING
1..100
1290
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PAHC's Valuation (4) in the Pharmaceuticals Major industry is in the same range as VTRS (5) in the null industry. This means that PAHC’s stock grew similarly to VTRS’s over the last 12 months.

PAHC's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as VTRS (100) in the null industry. This means that PAHC’s stock grew similarly to VTRS’s over the last 12 months.

VTRS's SMR Rating (73) in the null industry is in the same range as PAHC (82) in the Pharmaceuticals Major industry. This means that VTRS’s stock grew similarly to PAHC’s over the last 12 months.

VTRS's Price Growth Rating (4) in the null industry is somewhat better than the same rating for PAHC (50) in the Pharmaceuticals Major industry. This means that VTRS’s stock grew somewhat faster than PAHC’s over the last 12 months.

PAHC's P/E Growth Rating (12) in the Pharmaceuticals Major industry is significantly better than the same rating for VTRS (90) in the null industry. This means that PAHC’s stock grew significantly faster than VTRS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PAHCVTRS
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
70%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
76%
Bearish Trend 1 day ago
65%
Momentum
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
66%
MACD
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
71%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
71%
Bullish Trend 1 day ago
70%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
65%
Advances
ODDS (%)
Bullish Trend 7 days ago
70%
Bullish Trend 1 day ago
72%
Declines
ODDS (%)
Bearish Trend 22 days ago
68%
Bearish Trend 14 days ago
66%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
68%
Bearish Trend 1 day ago
66%
Aroon
ODDS (%)
Bearish Trend 1 day ago
84%
Bullish Trend 1 day ago
63%
View a ticker or compare two or three
Ad is loading...
PAHCDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VTRSDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PRSO1.760.23
+15.03%
Peraso
OCFT2.160.03
+1.41%
OneConnect Financial Technology Co Ltd
FTI19.940.22
+1.12%
TechnipFMC plc
GPRK8.40-0.23
-2.67%
Geopark Limited
UCTT41.82-2.49
-5.62%
Ultra Clean Holdings

PAHC and

Correlation & Price change

A.I.dvisor indicates that over the last year, PAHC has been loosely correlated with EGRX. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if PAHC jumps, then EGRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PAHC
1D Price
Change %
PAHC100%
+1.31%
EGRX - PAHC
41%
Loosely correlated
+0.25%
ELAN - PAHC
38%
Loosely correlated
-0.62%
PRGO - PAHC
38%
Loosely correlated
+0.91%
PBH - PAHC
37%
Loosely correlated
-0.55%
ASRT - PAHC
35%
Loosely correlated
-3.77%
More

VTRS and

Correlation & Price change

A.I.dvisor indicates that over the last year, VTRS has been loosely correlated with PRGO. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if VTRS jumps, then PRGO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VTRS
1D Price
Change %
VTRS100%
+1.38%
PRGO - VTRS
45%
Loosely correlated
+0.91%
TEVA - VTRS
39%
Loosely correlated
+0.38%
ELAN - VTRS
39%
Loosely correlated
-0.62%
PAHC - VTRS
34%
Loosely correlated
+1.31%
SIGA - VTRS
34%
Loosely correlated
-1.55%
More